肝脏 ›› 2024, Vol. 29 ›› Issue (3): 300-302.

• 肝癌 • 上一篇    下一篇

载药微球化疗栓塞术治疗中晚期肝癌患者疗效及对血清GGT、钙磷代谢的影响

苗晓飞, 王洪剑   

  1. 236000 安徽 阜阳市人民医院影像中心(苗晓飞),介入放射科(王洪剑)
  • 收稿日期:2023-11-12 出版日期:2024-03-31 发布日期:2024-05-16
  • 基金资助:
    2020年度安徽省自然科学基金(2008085MB32)

Effect of chemoembolization with drug-loaded microspheres on therapeutic effect and serum GGT, calcium and phosphorus metabolism in patients with advanced liver cancer

MIAO Xiao-fei1, WANG Hong-jian2   

  1. 1. Imaging Center, Fuyang People's Hospital, Anhui 236000, China;
    2. Department of Interventional Radiology, Fuyang People's Hospital, Anhui 236000, China
  • Received:2023-11-12 Online:2024-03-31 Published:2024-05-16

摘要: 目的 探讨中晚期肝癌患者采取载药微球化疗栓塞术的疗效。方法 选取2018年5月至2023年1月阜阳市人民医院收治的65例中晚期肝癌患者,按不同手术方法分为2组,对照组(肝动脉化疗栓塞术)31例,观察组(载药微球化疗栓塞术)34例,比较两组疗效。结果 观察组GGT(28.26±2.62)U/L低于对照组(53.99±3.71)U/L;CA19-9(6.84±0.26)U/mL低于对照组(12.58±0.48)U/mL;AFP(310.87±5.52)ng/mL低于对照组(459.26±6.18)ng/mL(t=32.522、60.674、102.256,P<0.05)。术后1个月,观察组血Ga(2.12±0.14)mmol/L、iPTH(179.56±19.52)pg/mL、钙磷乘积(45.86±3.62)mg2/dL均低于对照组的(2.20±0.15)mmol/L、(206.84±22.17)pg/mL、(51.47±4.26)mg2/dL,血P(1.56±0.13)mmol/L高于对照组(1.83±0.14)mmol/L,钙磷乘积(45.86±3.62)mg2/dL低于对照组(51.47±4.26)mg2/dL(t=2.224、5.275、5.737、8.062,均P<0.05)。 术后1个月,观察组ALT(44.26±3.52)U/L低于对照组(53.97±4.17)U/L,AST(36.85±5.14)U/L低于对照组(48.10±6.71)U/L,TBil(16.56±2.62)μmol/L低于对照组(21.45±3.05)μmol/L(t=10.174、7.627、6.951,P<0.05)。两组不良反应发生率对比(χ2 =0.300,P=0.584)。术后3个月,两组生存率为97.06%比90.32%,差异无统计学意义(χ2=0.375,P=0.540);术后6个月,两组生存率94.12%比70.97%,差异有统计学意义(χ2=6.181,P=0.013)。结论 载药微球化疗栓塞术治疗中晚期肝癌患者疗效确切,随访6个月患者生存率较高,值得推广。

关键词: 中晚期肝癌, 载药微球化疗栓塞术, 钙磷代谢

Abstract: Objective To investigate the efficacy of chemoembolization with drug-loaded microspheres in patients diagnosed with advanced liver cancer. Methods A total of 65 patients with advanced liver cancer treated between May 2018 and January 2023, were divided into 2 groups based on the surgical method used: control group (31 cases: conventional surgery) and observation group (34 cases: drug-loaded microsphere chemoembolization). The efficacy of these two treatment approaches was compared. Results The level of glutamyltransferase (GGT) in the observation group (28.26±2.62 U/L) was significantly lower compared to the control group (53.99±3.71 U/L). Similarly,the levels of CA19-9 (6.84±0.26 U/mL) and AFP (310.87±5.52 ng/ml) were also lower in the observation group than in the control group (459.26±6.18 ng/ml) (t=32.522, P<0.05; t value =60.674, P<0.05; t value=102.256, P<0.05). 1 month pose-surgery, the blood concentrations of Ca ( 2.12±0.14 mmol/L), iPTH (179.56±19.52 pg/mL) and Ca×P product (45.86±3.62 mg2/dL) in the observation group showed a significantly decrease compared to the control group (2.20±0.15 mmol/L, 206.84±22.17 pg/mL, 51.4 7±4.26 mg2/dL). Additionally, the level of blood phosphorus (1.56±0.13 mmol/L) was higher in the observation group than in the control group (1.83±0.14 mmol/L), while the product of calcium and phosphorus (45.86±3.62 mg2/dL) was lower in the observation group compared to the control group (51.47±4.26 mg2/dL) (t value=2.224, P<0.05; t value=5.275, P<0.05; t value=5.737, P<0.05; t value=8.062, P<0.05). Moreover, one month after the operation, the levels of ALT (44.26±3.52 U/L), AST (36.85±5.14 U/L), and Tbil (16.56±2.62) μmol/L were lower than those in the control group (53.97±4.17 U/L, 48.10±6.71 U/L, 21.45±3.05 μmol/L, respectively). (t=10.174, P<0.05; t value=7.627, P<0.05; t value=6.951, P<0.05). The incidence of adverse reactions between the two groups was compared (χ2=0.300, P=0.584). Survival rates at 3 month (χ2=0.375, P=0.540) and 6 months (χ2=6.181, P=0.013) after surgery were also compared. Conclusion Chemoembolization with drug-loaded microspheres has demonstrated effectiveness in the treatment advanced liver cancer patients, with a high survival rate observed at 6 months post-surgery. This treatment approach warrants further investigation and potential application in clinical practice.

Key words: Advanced liver cancer, Chemoembolization with drug-loaded microspheres, Calcium and phosphorus metabolism